Innovation to Impact: Drug Development, AI, and Regulatory Strategy

Brian Berridge, Nick Kelly & Szczepan Baran

Innovation to Impact is a podcast on decision-grade drug development in regulated environments.

We examine how high-stakes go/no-go calls are made inside pharma and biotech, and what evidence is required for new tools to change those decisions without creating hidden risk.

Each episode focuses on predictivity, translational risk, decision rights, and accountability (what breaks, who owns it, and what triggers a stop).

This is not a podcast about technology trends. It is about disciplined innovation that can survive audit, scale, and real-world biology.

Where can you listen?

Episodes

How many episodes are there of Innovation to Impact: Drug Development, AI, and Regulatory Strategy?

There are 6 episodes avaiable of Innovation to Impact: Drug Development, AI, and Regulatory Strategy.

What is Innovation to Impact: Drug Development, AI, and Regulatory Strategy about?

We have categorized Innovation to Impact: Drug Development, AI, and Regulatory Strategy as:

Business
Science
Management
Life Sciences

Where can you listen to Innovation to Impact: Drug Development, AI, and Regulatory Strategy?

Innovation to Impact: Drug Development, AI, and Regulatory Strategy is available, among others places, on:

Spotify
Apple Podcasts
Podtail
Google Podcasts

When did Innovation to Impact: Drug Development, AI, and Regulatory Strategy start?

The first episode of Innovation to Impact: Drug Development, AI, and Regulatory Strategy that we have available was released 15 February 2026.

Who creates the podcast Innovation to Impact: Drug Development, AI, and Regulatory Strategy?

Innovation to Impact: Drug Development, AI, and Regulatory Strategy is produced and created by Brian Berridge, Nick Kelly & Szczepan Baran.